RadNet’s subsidiary DeepHealth has concluded the $103m acquisition of iCAD, which was announced in April.
The move enhances DeepHealth’s goal to address the clinical and operational difficulties encountered in screening and diagnosis.
The integration combines iCAD’s commercial, technological and regulatory expertise with DeepHealth’s focus on leveraging AI and imaging to improve healthcare outcomes.
iCAD’s AI portfolio, which encompasses breast cancer identification, risk assessment, breast density, and breast arterial calcification evaluation, is utilised in more than 50 nations.
The merger of compatible technologies and datasets is expected to improve the performance of AI models, providing a range of AI-driven image interpretation and workflow tools that meet the practical clinical requirements throughout the cancer screening and detection process.
Additionally, the acquisition grants DeepHealth access to iCAD’s network of more than 1,500 healthcare provider locations worldwide.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThis strategic move is set to scale DeepHealth’s presence, potentially analysing over ten million mammograms annually. The expanded worldwide reach is poised to expedite AI adoption and screening compliance, especially in underserved communities.
RadNet operates a substantial network of outpatient imaging centres across several US states and offers various radiology information technologies and AI solutions under the DeepHealth brand.
RadNet Digital Health segment CEO and president Kees Wesdorp said: 鈥淲e are excited to welcome the iCAD team to DeepHealth.
“The integration of iCAD further empowers DeepHealth to meet the real-world clinical needs of today, from improving the accuracy and early detection of breast cancer to orchestrating large-scale screening programmes while shaping the future of breast cancer management.
鈥淥ur combined capabilities position us for accelerated growth and rapid delivery of transformative, AI-powered population health solutions.鈥�
In April, iCAD collaborated with Microsoft to incorporate a suite of AI-powered mammography solutions into its ProFound Breast Health Suite on the latter鈥檚 Precision Imaging Network (PIN).
